Published in Gene Therapy Weekly, April 3rd, 1995
Allovectin-7 is a gene-based product intended for direct injection into tumor lesions of cancer patients. The product contains a gene that encodes a mismatched transplantation antigen (HLA-B7) which, when injected into tumors, is intended to cause the malignant cells to bear the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.